These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 167254)

  • 21. Stereoselective actions of substituted benzamide drugs on cerebral dopamine mechanisms.
    Jenner P; Clow A; Reavill C; Theodorou A; Marsden CD
    J Pharm Pharmacol; 1980 Jan; 32(1):39-44. PubMed ID: 6102125
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of morphine on the rat striatal dopamine metabolism.
    Lee CM; Wong PC
    Biochem Pharmacol; 1979; 28(2):163-70. PubMed ID: 34399
    [No Abstract]   [Full Text] [Related]  

  • 23. Behavioral effects of apomorphine and diisobutyrylapomorphine in the mouse.
    Baldessarini RJ; Kula NS; Walton KG
    Psychopharmacology (Berl); 1977 Jun; 53(1):45-53. PubMed ID: 407613
    [No Abstract]   [Full Text] [Related]  

  • 24. Dopamine- and apomorphine-sensitive adenylate cyclase in homogenates of rabbit retina.
    Bucher MB; Schorderet M
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 288(1):103-7. PubMed ID: 169480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ontogenetic development of neostriatal dopamine receptors in the rat.
    Spano PF; Kumakura K; Govoni S; Trabucchi M
    J Neurochem; 1976 Aug; 27(2):621-4. PubMed ID: 987161
    [No Abstract]   [Full Text] [Related]  

  • 26. Narcotic dependence, narcotic action and dopamine receptors.
    Lal H
    Life Sci; 1975 Aug; 17(4):483-95. PubMed ID: 171531
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on dopamine kinetics in rat brain tissue under the influence of morphine.
    Kuschinsky K; Celsen B; Huppertz A
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):129-33. PubMed ID: 1172489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid development of hypersensitivity of striatal dopamine receptors induced by alpha-methylparatyrosine and its prevention by protein synthesis inhibitors.
    Costentin J; Marçais H; Protais P; Baudry M; De La Baume S; Martres MP; Schwartz JC
    Life Sci; 1977 Aug; 21(3):307-13. PubMed ID: 561281
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of bradykinin on central dopamine receptors.
    Przesmycki K; Kleinrok Z
    Pol J Pharmacol Pharm; 1976; 28(6):673-8. PubMed ID: 1034925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Actions of dopaminergic agonists on cyclic AMP production in rat brain homogenates.
    Iversen LL; Horn AS; Miller RJ
    Adv Neurol; 1975; 9():197-212. PubMed ID: 167565
    [No Abstract]   [Full Text] [Related]  

  • 31. Influence of chronic morphine treatment on dopaminergic sensitivity.
    Lucchelli A; Boselli C; Brunello N
    Pharmacol Res; 1990; 22 Suppl 3():35-6. PubMed ID: 2097635
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of morphine sulfate on adenylate cyclase and phosphodiesterase activities in rat corpus striatum.
    Puri SK; Cochin J; Volicer L
    Life Sci; 1975 Mar; 16(5):759-67. PubMed ID: 164598
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of morphine on striatal dopamine metabolism: possible mechanism of its opposite effect on locomotor activity in rats and mice.
    Kuschinsky K; Hornykiewicz O
    Eur J Pharmacol; 1974 Apr; 26(1):41-50. PubMed ID: 4598755
    [No Abstract]   [Full Text] [Related]  

  • 34. LSD as an agonist and antagonist at central dopamine receptors.
    Von Hungen K; Roberts S; Hill DF
    Nature; 1974 Dec; 252(5484):588-9. PubMed ID: 4431522
    [No Abstract]   [Full Text] [Related]  

  • 35. Multiple receptors for dopamine.
    Kebabian JW; Calne DB
    Nature; 1979 Jan; 277(5692):93-6. PubMed ID: 215920
    [No Abstract]   [Full Text] [Related]  

  • 36. Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferation.
    Carvey PM; Hitri A; Goetz CG; Tanner CM; Klawans HL
    Life Sci; 1988; 42(22):2207-15. PubMed ID: 3374255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of some derivatives of 2-aminotetralin on dopamine-sensitive adenylate cyclase and on the binding of (3H)haloperidol to neuroleptic receptors in the rat striatum.
    Cannon JG; Costall B; Laduron PM; Leysen JE; Naylor RJ
    Biochem Pharmacol; 1978 May; 27(10):1417-20. PubMed ID: 567987
    [No Abstract]   [Full Text] [Related]  

  • 38. Antagonism of the effects of chlorpromazine and morphine on dopamine metabolism by GABA.
    Lahti RA; Losey EG
    Res Commun Chem Pathol Pharmacol; 1974 Jan; 7(1):31-40. PubMed ID: 4811457
    [No Abstract]   [Full Text] [Related]  

  • 39. Interactions of morphine with apomorphine: behavioural and biochemical studies.
    Möller HG; Kuschinsky K
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):452-7. PubMed ID: 3821935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrophy of the striatum and motor disturbance induced by colchicine.
    Kamata K; Okuyama S; Hashimoto S; Kumura MA; Aihara H; Kasuya Y
    Brain Res; 1987 Sep; 421(1-2):353-7. PubMed ID: 3690277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.